Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$8.2 million.

  • Maravai Lifesciences Holdings' Cash from Financing Activities fell 111965.39% to -$8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$250.9 million, marking a year-over-year decrease of 2659123.55%. This contributed to the annual value of -$235.7 million for FY2024, which is 28584.38% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Cash from Financing Activities stood at -$8.2 million for Q3 2025, which was down 111965.39% from -$1.5 million recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Cash from Financing Activities peaked at $809000.0 during Q3 2024, and registered a low of -$236.2 million during Q4 2024.
  • For the 5-year period, Maravai Lifesciences Holdings' Cash from Financing Activities averaged around -$34.6 million, with its median value being -$24.1 million (2021).
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Cash from Financing Activities skyrocketed by 10209.12% in 2023, and later crashed by 5035297.87% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Cash from Financing Activities (Quarter) stood at -$49.6 million in 2021, then crashed by 33.37% to -$66.1 million in 2022, then skyrocketed by 100.71% to $470000.0 in 2023, then plummeted by 50352.98% to -$236.2 million in 2024, then skyrocketed by 96.51% to -$8.2 million in 2025.
  • Its Cash from Financing Activities was -$8.2 million in Q3 2025, compared to -$1.5 million in Q2 2025 and -$4.9 million in Q1 2025.